Cambridge Investment Research Advisors Inc. trimmed its holdings in shares of Nustar GP Holdings, LLC (NYSE:NSH) by 21.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,181 shares of the pipeline company’s stock after selling 2,756 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Nustar GP Holdings were worth $249,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of NSH. Trent Capital Management Inc. NC purchased a new position in shares of Nustar GP Holdings during the 2nd quarter worth approximately $201,000. Stifel Financial Corp purchased a new position in shares of Nustar GP Holdings during the 1st quarter worth approximately $206,000. Proficio Capital Partners LLC raised its stake in shares of Nustar GP Holdings by 11.0% during the 2nd quarter. Proficio Capital Partners LLC now owns 9,345 shares of the pipeline company’s stock worth $214,000 after buying an additional 925 shares in the last quarter. Alliancebernstein L.P. purchased a new position in shares of Nustar GP Holdings during the 1st quarter worth approximately $233,000. Finally, Janney Montgomery Scott LLC raised its stake in shares of Nustar GP Holdings by 1.0% during the 2nd quarter. Janney Montgomery Scott LLC now owns 10,150 shares of the pipeline company’s stock worth $248,000 after buying an additional 100 shares in the last quarter. 55.59% of the stock is owned by institutional investors and hedge funds.

A number of brokerages have recently issued reports on NSH. TheStreet raised Nustar GP Holdings from a “c+” rating to a “b” rating in a research note on Thursday, May 25th. Zacks Investment Research raised Nustar GP Holdings from a “strong sell” rating to a “hold” rating in a research note on Saturday, July 29th. BidaskClub raised Nustar GP Holdings from a “strong sell” rating to a “sell” rating in a research note on Friday, August 25th. Wells Fargo & Company downgraded Nustar GP Holdings from an “outperform” rating to a “market perform” rating in a research note on Monday, July 17th. Finally, Credit Suisse Group set a $28.00 price objective on Nustar GP Holdings and gave the company a “hold” rating in a research note on Sunday, July 30th. One equities research analyst has rated the stock with a sell rating and eight have issued a hold rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $28.33.

TRADEMARK VIOLATION NOTICE: This article was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another publication, it was copied illegally and reposted in violation of US and international copyright laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/09/20/cambridge-investment-research-advisors-inc-has-249000-stake-in-nustar-gp-holdings-llc-nsh.html.

Nustar GP Holdings, LLC (NYSE:NSH) opened at 22.00 on Wednesday. The company has a 50-day moving average price of $21.56 and a 200 day moving average price of $24.88. Nustar GP Holdings, LLC has a 1-year low of $20.04 and a 1-year high of $31.50. The stock has a market capitalization of $944.92 million, a P/E ratio of 10.32 and a beta of 1.19.

Nustar GP Holdings (NYSE:NSH) last announced its earnings results on Friday, July 28th. The pipeline company reported $0.56 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.35 by $0.21. Nustar GP Holdings had a return on equity of 25.68% and a net margin of 176.62%. The firm had revenue of $10.96 million for the quarter, compared to analysts’ expectations of $16.22 million. On average, equities analysts predict that Nustar GP Holdings, LLC will post $2.27 EPS for the current year.

In other news, Director William E. Greehey bought 42,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 9th. The shares were purchased at an average price of $21.79 per share, with a total value of $926,075.00. Following the completion of the acquisition, the director now directly owns 8,646,280 shares in the company, valued at $188,402,441.20. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William E. Greehey bought 20,279 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were purchased at an average cost of $20.85 per share, for a total transaction of $422,817.15. Following the acquisition, the director now owns 8,716,559 shares of the company’s stock, valued at $181,740,255.15. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 173,086 shares of company stock worth $3,715,871. 21.39% of the stock is owned by corporate insiders.

Nustar GP Holdings Company Profile

NuStar GP Holdings, LLC holds interests in NuStar Energy L.P. (NuStar Energy). NuStar Energy is engaged in the transportation of petroleum products and anhydrous ammonia, the terminalling and storage of petroleum products and the marketing of petroleum products. NuStar Energy has terminal and storage facilities in the United States, Canada, Mexico, the Netherlands, including St.

Want to see what other hedge funds are holding NSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nustar GP Holdings, LLC (NYSE:NSH).

Institutional Ownership by Quarter for Nustar GP Holdings (NYSE:NSH)

Receive News & Stock Ratings for Nustar GP Holdings LLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nustar GP Holdings LLC and related stocks with our FREE daily email newsletter.